Method and compositions for making ACSF and ACSF antagonists
AssigneesThe University of Melbourne, Genentech, Inc.
InventorsWilliam I. Wood, Thomas John Martin
Life of this patent
Estimating the term…
Abstract
The complete amino acid and nucleotide sequence for adenylate cyclase stimulating factor is provided, thereby facilitating the synthesis of ACSF in recombinant cell culture. ACSF amino acid sequence variants and ACSF antibodies are provided which are useful in the treatment of humoral hypercalcemia of malignancy or in immunoassays for ACSF. In particular, antibodies capable of binding only the C-terminal domains of ACSF are useful in immunoassays for ACSF which avoid interference by parathyroid hormone. Also provided are novel polypeptides selected from the group of the ACSF basic peptide, the ACSF C-terminal peptide, or the ACSF domain containing both of the basic and C-terminal peptides.
Claims7
A composition comprising a biologically active Adenylate Cyclase Stimulating Factor (ACSF) polypeptide consisting of either the basic domain of ACSF from about residues 84 to 108 or the basic domain of ACSF and the C terminal domain of ACSF from about residues 109 to 141.
A composition comprising a biologically active Adenylate Cyclase Simulating Factor (ACSF) polypeptide selected from the group consisting of:
- KTPGKKKKGKPGKRKEQEKKKRRTR
- KTPGKKKKGKPGKRPEQEKKKRRTR;
- KTPGKKKKGKPGERKEQEKKXPRTR;
- KTPGKKYKGKPGKRKEQEKKKRRTR;
- KTPGKWKKGKPGKRKEQEKKKRRTR;
- and
- KTPGKKKKGKPGHRKEQEKKKRRTR.
A composition comprising a biologically active Adenylate Cyclase Stimulating Factor (ACSF) polypeptide selected from the group consisting of:
- SAWLDSGVTGSGLEGDHLSDTSTTSLELDSRRH;
- SFWLDSGVTGSGLEGDHLSDTSTTSLELDSRRH;
- SAWLDSGVYGSGLEGDHLSDTSTTSLELDSRRH;
- SAWLDSGVTGSGLDGDHLSDTSTTSLELDSRRH;
- SAWLDSGVTGSGLEGDKLSDTSTTSLELDSRRH;
- SAWLDSGVTGSGLEGDHLSDTSTYSLELDSRRH;
- and
- SAWLDSGVTGSGLEGDHLSDTSTTALELDSRRH.
Dependencies are inferred from the claim text.